文献速递分子诊断临床微生物

FluoroType MTBDR 检测结核分枝杆菌复合群利福平与异烟肼耐药性的验证

Validation of the FluoroType MTBDR Assay for Detection of Rifampin and Isoniazid Resistance in Mycobacterium tuberculosis Complex Isolates.
PubMed 文献 · J Clin Microbiol · 2018-05-25

该研究以 180 株结核分枝杆菌复合群培养分离株为对象,比较 FluoroType MTBDR 与表型药敏试验(DST)检测利福平和异烟肼耐药性的表现,并用 Genotype MTBDRplus 及 Sanger 测序复核不一致结果。FluoroType MTBDR 对利福平和异烟肼的特异性均为 100%,对异烟肼敏感性 91.7%、对利福平敏感性 98.9%。

要点

  • FluoroType MTBDR 对培养分离株利福平和异烟肼耐药检测特异性均为 100%。
  • 对利福平耐药敏感性 98.9%,对异烟肼耐药敏感性 91.7%。
  • 结果基于 180 株培养分离株,与表型 DST 比较。

核心结论

  • 使用培养分离株时,FluoroType MTBDR 对利福平和异烟肼耐药检测具有高敏感性和高特异性。

研究设计与样本

  • 研究纳入 180 株 MTBC 培养分离株,进行表型 DST,并同时用 FluoroType MTBDR 和 Genotype MTBDRplus 检测。
  • 对表型与分子结果不一致的分离株,以及 Genotype MTBDRplus 特定野生型条带缺失的分离株,进行 rpoB、katG、inhA 和 aphC 关键区域 Sanger 测序。
  • 以表型 DST 为参照,计算 FluoroType MTBDR 判定敏感和耐药的正确比例作为特异性和敏感性。

主要发现

  • 表型 DST 显示 85 株对异烟肼和利福平敏感,7 株单耐异烟肼,7 株单耐利福平,81 株耐多药。
  • FluoroType MTBDR 对利福平和异烟肼的特异性均为 100%(95% CI 96.0–100%)。
  • FluoroType MTBDR 对异烟肼敏感性为 91.7%(95% CI 83.6–96.6%),对利福平敏感性为 98.9%(95% CI 93.8–100.0%)。

关键数值与推荐

  • 特异性定义为与表型 DST 相比正确判定为敏感的分离株比例,利福平和异烟肼均为 100%(95% CI 96.0–100%)。
  • 敏感性定义为与表型 DST 相比正确判定为耐药的分离株比例,异烟肼 91.7%(95% CI 83.6–96.6%),利福平 98.9%(95% CI 93.8–100.0%)。

临床怎么用

  • FluoroType MTBDR 可用于培养分离株的利福平和异烟肼耐药快速分子检测。
  • 对异烟肼耐药检测敏感性略低于利福平,解读阴性结果时需结合临床和表型 DST。

局限性

  • 研究仅使用培养分离株,未在直接临床标本中验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

For Mycobacterium tuberculosis complex (MTBC), the rapid and accurate diagnosis of drug resistance is crucial to ensure early initiation of appropriate therapy. Recently, a new molecular diagnostic test, the FluoroType MTBDR, aimed at detecting rifampin and isoniazid resistance has become available. This study aimed to evaluate the FluoroType MTBDR in comparison to phenotypic drug susceptibility testing (DST) using M. tuberculosis complex isolates. MTBC isolates underwent phenotypic DST and were tested using the FluoroType MTBDR and Genotype MTBDRplus. Sanger sequencing of the key regions of rpoB, katG, inhA, and aphC was performed for isolates with discordant phenotypic and molecular results. Furthermore, isolates with specific wild-type bands missing in the Genotype MTBDRplus, indicating the presence of a mutation, were investigated by Sanger sequencing. Specificity and sensitivity, defined as the proportions of isolates correctly determined as susceptible and resistant by the FluoroType MTBDR compared to phenotypic DST, were calculated. A total of 180 culture isolates were included; phenotypic DST showed 85 isolates susceptible to isoniazid and rifampin, 7 with isoniazid monoresistance, 7 with rifampin monoresistance, and 81 with multidrug resistance. The specificity of the FluoroType MTBDR was 100% (95% confidence interval [CI], 96.0 to 100%) for both rifampin and isoniazid. The sensitivity was 91.7% (95% CI, 83.6 to 96.6%) for isoniazid and 98.9% (95% CI, 93.8 to 100.0%) for rifampin. The FluoroType MTBDR has a high sensitivity and specificity for the detection of rifampin and isoniazid resistance when using culture isolates.

来源:J Clin Microbiol,查看原文。版权归原作者所有。

引用

  1. Hillemann D, Haasis C, Andres S, et al. Validation of the FluoroType MTBDR Assay for Detection of Rifampin and Isoniazid Resistance in Mycobacterium tuberculosis Complex Isolates. J Clin Microbiol. 2018. PMID: 29593055. doi:10.1128/JCM.00072-18

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。